NCT07792603

Brief Summary

This study evaluates the acute and chronic effects of an essential amino acid supplement (Daily Upgrade EAA+) on metabolomics, amino acid kinetics, metabolic rate, body composition in active adult women. The study consists of an acute randomized double-blind crossover phase comparing EAA+, whey protein isolate, and placebo before high-intensity interval training (HIIT), and a chronic randomized double-blind parallel-arm phase evaluating 3 weeks of EAA+ or placebo supplementation combined with twice-weekly HIIT.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 28, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

August 28, 2026

Status Verified

August 1, 2026

Enrollment Period

7 months

First QC Date

August 25, 2026

Last Update Submit

August 25, 2026

Conditions

Keywords

Dietary SupplementExercise trainingAmino AcidBody composition

Outcome Measures

Primary Outcomes (2)

  • Essential Amino Acid Kinetics

    Area under the curve for metabolomic responses

    Baseline, 30, 60, and 90 minutes following supplementation during acute visits.

  • Substrate Oxidation

    Respiratory exchange ratio (RER)

    Before (0 min) and after (30, 60, 90 min) one session of high intensity interval training

Secondary Outcomes (3)

  • Lean Body Mass

    Baseline and week 4

  • Muscle size

    Baseline week 4

  • Fluid Kinetics

    Baseline, week 1, week 2, week 3, week 4

Other Outcomes (3)

  • Muscle Oxygen Capacity

    Baseline and week 4

  • Mood

    Baseline, week 4

  • Skin

    Baseline, week 4

Study Arms (3)

Essential Amino Acids+

EXPERIMENTAL

Essential amino acids, creatine, magnesium, electrolytes consumed once (daily) with 8-12 oz of water.

Dietary Supplement: Essential Amino Acid+ plus HIIT

Placebo Comparator

PLACEBO COMPARATOR

Non-caloric placebo consumed once (daily) with 8-12 oz of water

Behavioral: Placebo plus HIIT

Whey Protein Isolate

ACTIVE COMPARATOR

1 serving whey protein isolate mixed with 8-12 oz of water

Dietary Supplement: No Exercise

Interventions

Daily supplementation plus twice weekly supervised high intensity interval training for 3 weeks

Essential Amino Acids+

Daily supplementation with non-caloric placebo, plus twice weekly supervised high intensity interval training for 3 weeks.

Placebo Comparator
No ExerciseDIETARY_SUPPLEMENT

No exercise, acute evaluation, whey protein intake only

Whey Protein Isolate

Eligibility Criteria

Age25 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBiological females only
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Participant is an adult between the ages of 25-45 years
  • Participant has a recorded BMI between 18.5-30 kg/m\^2
  • Participant is apparently healthy and free from disease, as determined by a health history questionnaire
  • Participant is a biological female
  • Participant is naturally menstruating or uses a form of hormonal contraceptive
  • Participant is recreationally active, based on the International Physical Activity Questionnaire- Short Form
  • Participant agrees to abstain from caffeine (12 hours), tobacco, alcohol, and exercise for 24 hours prior to testing days
  • Participant is willing and able to comply with the protocol

You may not qualify if:

  • Participant has been diagnosed with chronic heart disease, arrhythmias, thyroid disease, renal, hepatic, autoimmune or neurological diseases, as determined by a health history questionnaire.
  • Participant has a musculoskeletal disorder or injury that would prohibit them from being able to safely complete the study protocol.
  • Participant is currently enrolled in a separate clinical trial or weight loss program involving diet, exercise, physical activity, or the potential ingestion of an active drug or dietary supplement
  • Participant is using, or has consistently used one of the following dietary supplements within 1 month prior to enrollment: whey protein, creatine, essential amino acids
  • Participant has a known allergy or sensitivity to the placebo or active ingredients
  • Participant is pregnant or planning to become pregnant
  • Participant does not speak English or is hearing impaired

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Applied Physiology Laboratory

Chapel Hill, North Carolina, 27599, United States

Location

MeSH Terms

Interventions

Amino Acids, Essential

Intervention Hierarchy (Ancestors)

Amino AcidsAmino Acids, Peptides, and Proteins

Study Officials

  • Abbie Smith-Ryan, PhD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Abbie Smith-Ryan, PhD

CONTACT

Research Coordinator

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This study incorporates two randomized intervention components within a single protocol. The primary trial is a double-blind, parallel-group study in which participants are randomized to receive either Daily Upgrade EAA+ or placebo during a 3-week supervised high-intensity interval training (HIIT) intervention. Embedded within the overall trial is an acute, randomized, double-blind crossover substudy in which a subset of participants completes three experimental visits and receives Daily Upgrade EAA+, whey protein isolate, and placebo in randomized order to evaluate acute metabolomic, metabolic, and physiological responses before and after HIIT.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 25, 2026

First Posted

August 28, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

August 28, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations